Improving patient access to treatment
Developing therapies isn’t enough. Sanofi also tries to address various barriers to treatment access globally.
Sanofi's Humanitarian Programs provide several of its therapies free to people for whom treatment may be financially or logistically beyond their means, and who qualify.
Even with free drug programs or other forms of funding like the Humanitarian Programs, patient access to treatment can still be impeded by other issues: logistical and bureaucratic difficulties, inadequate healthcare facilities, or lack of knowledge. In addition to donating its products, Sanofi collaborates with governments, healthcare providers, humanitarian organisations, and other local partners to overcome barriers to treatment, build sustainable healthcare systems, and improve standards of care.
Global patient advocacy
Sanofi’s internal patient advocacy group works with and supports numerous patient organisations worldwide to achieve its common mission: advocating for and addressing the needs of patients with serious medical conditions.
In partnership with patient organisations, Sanofi:
- Champions the patient perspective within the company
- Advocates for access to therapies
- Empowers patients to have informed discussions with their healthcare providers
- Supports advocacy leaders
Guiding principles that define our relationships with patient advocacy groups
- Mutual respect
- Data privacy
- Open and honest communications
- Collaboration and partnerships
- Highest standard of ethics and integrity
- Transparency
Contact
Education and outreach
Sanofi is committed to raising awareness about diseases, educating both patients and the medical community, and advancing research and quality of care.
MAT-XU-2305426 (v1.0)
Date of preparation: March 2024